ArticleFrontiers in microbiology2022
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 23 citations in OpenAlex.
- TargetingPlants (Basel, Switzerland) · 2026Article
- Article
- Screening and Quality Evaluation of Submerged Culture Media Formulations forJournal of fungi (Basel, Switzerland) · 2026Article
- Isolation of a native strain of Clonostachys rosea with insecticidal, antiphytopathogenic, and endophytic activities.Archives of microbiology · 2025Article
- One fungus, two foes: Clonostachys rosea as a biocontrol agent against root-knot nematode, Meloidogyne incognita and Fusarium wilt disease complex in ridge gourd.Archives of microbiology · 2025Article
- A case of corneal infection with Clonostachys rosea.BMC infectious diseases · 2025Article
- Advances in submerged liquid fermentation and formulation of entomopathogenic fungi.Applied microbiology and biotechnology · 2024Review
- Large-scale production of myco-fabricated ZnO/MnO nanocomposite using endophytic Colonstachys rosea with its antimicrobial efficacy against human pathogens.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among the prospective biocontrol agents, the saprophytic filamentous fungus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.